HOME >> BIOLOGY >> NEWS
Study shows cognitive decline is not normal in aging

Finding opens door to prevention by showing older people with atherosclerosis or diabetes in combination with the ApoE4 gene are at much higher risk for memory loss, cognitive decline.

(Sacramento, Calif.) -- In a study that tracked changes in cardiovascular health and cognitive function in 5,888 community-dwelling senior citizens annually over a ten-year period, researchers at UC Davis School of Medicine and Medical Center say cognitive decline is not a normal part of aging for the majority of elderly people. In fact, only people with high levels of atherosclerosis or diabetes and also those with the apolipoprotein E4 gene associated with Alzheimer's disease are both at high risk for a decline in cognitive ability as they age. The results of the study are reported in the July 7 issue of the Journal of the American Medical Association.

"Seventy percent of individuals evaluated in this study showed no significant decline in cognitive function over the study period," says Mary N. Haan, director of the UC Davis Center for Aging and Health and lead author of the study. "We found that individuals whose cognitive ability remained constant during the study had two factors in common: they did not carry any of the apolipoprotein E4 genes, which is often associated with Alzheimer's disease, and they had little or no signs of diabetes or atherosclerosis."

In comparison, the researchers found that the greatest loss of cognitive ability occurred in people who had both high levels of atherosclerosis or diabetes and an Apo4E gene. These individuals were eight times more likely to show a decline in function compared to people with a low level of atherosclerosis and no genetic predisposition. Individuals with an E4 allele were three-to-four times more likely to show a decline in function than individuals without this genotype. And those with high levels of atherosclerosis were three times more likely to show a loss of function th
'"/>

Contact: Carole Gan
cfgan@ucdavis.edu
916-734-9047
University of California, Davis - Health System
6-Jul-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2020)... ... April 27, 2020 , ... Ofee.com, an online experience ... teenagers with an idea to help millions of people during the coronavirus lockdown. ... need and suffering, an outlet has been created for people to meet online ...
(Date:4/22/2020)... ... 2020 , ... RCH Solutions (RCH ), a global provider of Bio-IT ... of Michael Wlodarczyk as Director of Sales and Business Development. Based out of RCH’s ... already strong presence across the Northeast. , “We continue to see increased demand for ...
(Date:4/18/2020)... , ... April 16, 2020 , ... SIRION Biotech ... cell therapy, today announced it will present a company update on its work expediting ... Summit taking place on April 22 and 23. Dieter Lingelbach, the Company’s Chief ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... ... May 05, 2020 , ... ... today the launch of its iGlucose® LTE Cat-M Cellular Connected Diabetes ... LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity available, to provide ...
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. announced ... applications and services for use on Microsoft Azure. The customer experience management (CXM) ... online for a built-for-purpose customer engagement capability to use in their commercial or ...
(Date:4/22/2020)... and CAMBRIDGE, Mass. (PRWEB) , ... April 20, ... ... Budapest with US offices in Cambridge, MA, announced today that Omixon’s founder and ... the early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
Breaking Biology Technology:
Cached News: